Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01353625
Title Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene Corporation
Indications

chronic lymphocytic leukemia

prolymphocytic leukemia

CLL/SLL

multiple myeloma

prostate cancer

Advanced Solid Tumor

non-Hodgkin lymphoma

Ewing sarcoma of bone

Therapies

CC-115

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.